These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6812967)

  • 21. Time-related changes in the synthesis and secretion of very low density, low density and high density lipoproteins by cultured rat hepatocytes.
    Bell-Quint J; Forte T
    Biochim Biophys Acta; 1981 Jan; 663(1):83-98. PubMed ID: 7213773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein (a) is not a metabolic product of other lipoproteins containing apolipoprotein B.
    Krempler F; Kostner G; Bolzano K; Sandhofer F
    Biochim Biophys Acta; 1979 Oct; 575(1):63-70. PubMed ID: 228736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of khellin and timefurone on secretion and catabolism of lipoproteins by cultured human and rabbit hepatocytes].
    Volgushev SA; Kosykh VA; Podrez EA; Novikov DK; Fuki IV; Karpov RS; Repin VS
    Biokhimiia; 1990 Feb; 55(2):346-51. PubMed ID: 2340318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of tocopherol and apolipoprotein A-I immunoreactivity in rat liver chromatin.
    Panin LE; Polyakov LM; Kolosova NG; Russkikh GS; Poteryaeva ON
    Membr Cell Biol; 1998; 11(5):631-40. PubMed ID: 9672881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
    Venkatesan N; Devaraj SN; Devaraj H
    Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia.
    Havel RJ; Chao Y; Windler EE; Kotite L; Guo LS
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4349-53. PubMed ID: 6933487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipoprotein metabolism].
    Corvilain B
    Rev Med Brux; 1997 Feb; 18(1):3-9. PubMed ID: 9132915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Predictive value of apolipoproteine E genotypes].
    Martenka J; Soszyńska K
    Wiad Lek; 2016; 69(3 pt 2):569-575. PubMed ID: 28478428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of nascent lipoproteins produced by perfused rat liver: evidence of hepatic secretion and post-secretory modification of nascent lipoproteins.
    Teramoto T; Watanabe T; Matsushima T; Horie Y; Oka H
    J Biochem; 1990 Apr; 107(4):519-25. PubMed ID: 2358425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Endogenic hypertriglyceridemia and arteriosclerosis in the light of experimental studies].
    Naruszewicz M
    Przegl Lek; 1982 Sep; 39(8):555-60. PubMed ID: 6753043
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of cerium on liver lipids metabolism and plasma lipoproteins synthesis in the rat.
    Renaud G; Soler-Argilaga C; Infante R
    Biochem Biophys Res Commun; 1980 Jul; 95(1):220-7. PubMed ID: 7417251
    [No Abstract]   [Full Text] [Related]  

  • 33. Interaction of beta-very-low-density lipoproteins with rat liver cells.
    Harkes L; van Duijne A; van Berkel TJ
    Eur J Biochem; 1989 Mar; 180(1):241-8. PubMed ID: 2707263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoproteins induced by an antimitotic agent.
    Dousset N; Loudet AM; Lespine A; Carton M; Douste-Blazy L; Chap H
    Adv Exp Med Biol; 1987; 210():201-8. PubMed ID: 3591549
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of insulin in lipoprotein secretion by cultured rat hepatocytes.
    Patsch W; Franz S; Schonfeld G
    J Clin Invest; 1983 May; 71(5):1161-74. PubMed ID: 6343434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
    Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM
    N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of human C apolipoproteins on the in vitro hepatic metabolism of triglyceride emulsions in the rat.
    Quarfordt SH; Michalopoulos G; Schirmer B
    J Biol Chem; 1982 Dec; 257(24):14642-7. PubMed ID: 7174660
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of arterial lipoproteins in the formation of the fibrous plaque.
    Hollander W
    Adv Exp Med Biol; 1977; 82():793-9. PubMed ID: 200107
    [No Abstract]   [Full Text] [Related]  

  • 39. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
    Krul ES; Tikkanen MJ; Cole TG; Davie JM; Schonfeld G
    J Clin Invest; 1985 Feb; 75(2):361-9. PubMed ID: 3973009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.